Register Interest in Lung Test
John F. Halsey, PhD
Dr. Halsey is the President, Chief Executive Officer and Clinical Laboratory Director of IBT Laboratories. IBT, which was founded by Dr. Halsey, is a national clinical laboratory that provides specialized molecular and cellular immunology testing to all of the major clinical laboratory companies in the U.S. In addition, the laboratory performs contract research for many global pharmaceutical, biotechnology and in-vitro diagnostic companies. Dr. Halsey received his doctoral degree from the Johns Hopkins University and did post-doctoral research at the University of Virginia School of Medicine and the Medical University of South Carolina. While a tenured faculty member in the department of biochemistry and molecular biology at the University of Kansas School of Medicine he directed an NIH funded research program in mucosal immunology and vaccine immunology. During his tenure at the university he was director of graduate studies and served as a panel member of several NIH study sections. Dr. Halsey has 24 years experience in clinical laboratory operations and is an expert in clinical laboratory regulation. Over the past two decades he has developed and launched many new clinical immunology tests. Under his direction, the company gained FDA approval for a number of unique immunoassays. He is the past chair of the Clinical Laboratory Immunology Committee of the American Academy of Allergy Asthma and Immunology. He currently serves as a consultant to the FDA’s Immunology Devices Panel. In addition, he is an advisor to the Clinical and Laboratory Standards Institute (Formerly NCCLS) and the College of American Pathology CPT Coding Caucus.